Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Comparison of Poractant Alfa and Calfactant via LISA in Preterm Infants With RDS
NCT07350018Phase 4Recruiting
- Sponsor
- Bursa Uludag University
- Start
- Jan 2026
- Primary completion
- Feb 2027
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 4 trial of Poractant alfa, calfactant in respiratory distress syndrome (RDS), sponsored by Bursa Uludag University. Started Jan 2026; status: recruiting.
02
Drugs
Poractant alfacalfactant
03
Conditions
respiratory distress syndrome (RDS)
Beyond the preview
Go deeper on NCT07350018.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07350018.